Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Non-Current Assets (2018 - 2025)

TransMedics has reported Non-Current Assets over the past 8 years, most recently at $430.6 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $430.6 million for Q4 2025, up 40.32% from a year ago — trailing twelve months through Dec 2025 was $1.4 billion (up 31.6% YoY), and the annual figure for FY2025 was $430.6 million, up 40.32%.
  • Non-Current Assets for Q4 2025 was $430.6 million at TransMedics, up from $333.0 million in the prior quarter.
  • Over the last five years, Non-Current Assets for TMDX hit a ceiling of $430.6 million in Q4 2025 and a floor of $4.7 million in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $75.5 million (2023), compared with a mean of $148.4 million.
  • Biggest five-year swings in Non-Current Assets: fell 9.29% in 2021 and later soared 1148.75% in 2024.
  • TransMedics' Non-Current Assets stood at $9.8 million in 2021, then surged by 95.34% to $19.2 million in 2022, then soared by 916.45% to $195.4 million in 2023, then surged by 57.05% to $306.9 million in 2024, then skyrocketed by 40.32% to $430.6 million in 2025.
  • The last three reported values for Non-Current Assets were $430.6 million (Q4 2025), $333.0 million (Q3 2025), and $332.4 million (Q2 2025) per Business Quant data.